RCKT

$0.00

(

+0.00%

)
Quote details

stock

Rocket Pharmaceuticals Inc

NASDAQ | RCKT

4.25

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 14, 2025)

$374.43M

Market Cap

-

P/E Ratio

-2.51

EPS

$18.89

52 Week High

$2.19

52 Week Low

HEALTHCARE

Sector

RCKT Chart

Recent Chart
Price Action

RCKT Technicals

Tags:

RCKT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$9.4M
Total Revenue $0
Cost Of Revenue $9.4M
Costof Goods And Services Sold $9.4M
Operating Income -$273M
Selling General And Administrative $102M
Research And Development $171M
Operating Expenses $273M
Investment Income Net -
Net Interest Income $14M
Interest Income $16M
Interest Expense $1.9M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $9.4M
Income Before Tax -$259M
Income Tax Expense -$1
Interest And Debt Expense -
Net Income From Continuing Operations -$259M
Comprehensive Income Net Of Tax -
Ebit -$257M
Ebitda -$247M
Net Income -$259M

Revenue & Profitability

Earnings Performance

RCKT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $528M
Total Current Assets $378M
Cash And Cash Equivalents At Carrying Value $164M
Cash And Short Term Investments $164M
Inventory -
Current Net Receivables -
Total Non Current Assets $150M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $25M
Intangible Assets Excluding Goodwill $25M
Goodwill $39M
Investments -
Long Term Investments $0
Short Term Investments $209M
Other Current Assets $5.8M
Other Non Current Assets -
Total Liabilities $64M
Total Current Liabilities $41M
Current Accounts Payable $1.6M
Deferred Revenue -
Current Debt -
Short Term Debt $2.9M
Total Non Current Liabilities $24M
Capital Lease Obligations $25M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $25M
Other Current Liabilities $36M
Other Non Current Liabilities $1.1M
Total Shareholder Equity $463M
Treasury Stock -
Retained Earnings -$1.2B
Common Stock $1.1M
Common Stock Shares Outstanding $95M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$210M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $9.4M
Capital Expenditures $5.9M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $132M
Cashflow From Financing $186M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $0
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$259M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$9.4M
Total Revenue $0
Cost Of Revenue $9.4M
Costof Goods And Services Sold $9.4M
Operating Income -$273M
Selling General And Administrative $102M
Research And Development $171M
Operating Expenses $273M
Investment Income Net -
Net Interest Income $14M
Interest Income $16M
Interest Expense $1.9M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $9.4M
Income Before Tax -$259M
Income Tax Expense -$1
Interest And Debt Expense -
Net Income From Continuing Operations -$259M
Comprehensive Income Net Of Tax -
Ebit -$257M
Ebitda -$247M
Net Income -$259M

RCKT News

RCKT Profile

Rocket Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Rocket Pharmaceuticals, Inc. is an innovative biotechnology company based in Cranbury, New Jersey, dedicated to advancing gene therapies aimed at treating rare and life-threatening pediatric disorders. With a strong focus on leveraging its proprietary platform technologies, Rocket is at the forefront of delivering transformative therapeutic solutions that address significant unmet medical needs. The company's robust pipeline underscores its commitment to improving patient outcomes and reshaping the landscape of treatment for severe genetic diseases through cutting-edge science and a patient-centric approach.

VHAI
+66.66%
$0.00
YYAI
-9.70%
$0.15
BURU
-18.90%
$0.41
CGBS
-39.47%
$0.03
BITF
+11.87%
$6.03
NVDA
-3.57%
$181.59
NVTS
+28.93%
$12.85
TMQ
+47.54%
$9.67
PLUG
-0.25%
$3.89
CAN
+17.43%
$1.78
DNN
+5.19%
$3.24
RGTI
+1.74%
$55.87
LAES
+19.88%
$7.34
ITP
+24.30%
$0.32
BYND
-22.70%
$0.80
EDHL
+95.69%
$0.97
INTC
-2.12%
$36.42
AXDX
-61.36%
$0.03
F
+1.81%
$11.75
CRML
+28.39%
$29.88
RXRX
+2.35%
$5.66
JOBY
+8.19%
$18.14
DVLT
+14.70%
$1.95
NAK
+2.81%
$2.73
IONZ
+6.95%
$2.46
DFLI
+44.03%
$1.57
ACHR
+2.46%
$13.08
GPUS
-6.62%
$0.40
AMD
+3.30%
$223.58
TSLA
-0.54%
$433.54
WULF
+12.21%
$15.71
ETHD
+5.41%
$3.51
TLRY
-2.96%
$1.63
ONDS
+17.24%
$10.81
MARA
+11.24%
$22.51
MP
+21.34%
$95.06
ERIC
+19.76%
$9.78
QBTS
+7.17%
$43.53
SOUN
+9.19%
$20.90
NUAI
+28.95%
$3.03
UUUU
+11.50%
$26.50
BTBT
+7.50%
$4.30
RR
+0.79%
$6.50
UAMY
+36.85%
$16.71
AAL
+3.79%
$12.18
KDLY
-1.56%
$0.85
BBD
+2.34%
$3.16
CLF
+2.20%
$14.13
SOFI
+3.38%
$28.05
NOK
-1.31%
$5.25
JDZG
+44.14%
$2.71
CIFR
+3.93%
$21.14
AREC
+30.92%
$6.51
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
AMZN
+1.71%
$220.07
ADAP
-10.05%
$0.16
CLSK
+11.02%
$22.25
IREN
+9.35%
$70.14
APLD
+4.26%
$35.70
RIG
-1.87%
$3.14
USAR
+2.43%
$39.62
SRM
+53.27%
$10.30
PLTR
+2.50%
$181.65
BTG
+1.22%
$5.37
NIO
-3.06%
$6.95
ABAT
+18.65%
$10.94
QUBT
+3.86%
$22.29
ASST
-5.09%
$1.02
WWR
+14.25%
$2.92
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
RF
+2.42%
$25.15
BMNR
-4.52%
$54.28
WLGS
-5.57%
$0.04
SNAP
-0.64%
$7.99
QS
-2.14%
$16.62
GGB
+2.85%
$3.24
ETWO
0.00%
$3.30
JBLU
+9.45%
$4.98
GWH
-19.99%
$7.24
RGTZ
-3.00%
$9.02
EOSE
+2.55%
$17.48
PFE
-0.14%
$24.69
BCRX
-11.29%
$6.24
ATXS
+38.84%
$11.76
AFMD
-34.94%
$0.18
NAKA
-6.15%
$0.80
BAC
+3.18%
$50.41
ABEV
+1.40%
$2.17
AQMS
+140.56%
$23.84
GWAV
+88.96%
$16.08
GDXD
+0.44%
$0.73
NB
+4.41%
$11.81
GRAB
+0.59%
$5.96
VALE
0.00%
$11.01
REKR
+22.35%
$2.54
OPI
-16.97%
$0.20
WFC
+7.55%
$84.88
URG
+5.67%
$2.14
VHAI
+66.66%
$0.00
YYAI
-9.70%
$0.15
BURU
-18.90%
$0.41
CGBS
-39.47%
$0.03
BITF
+11.87%
$6.03
NVDA
-3.57%
$181.59
NVTS
+28.93%
$12.85
TMQ
+47.54%
$9.67
PLUG
-0.25%
$3.89
CAN
+17.43%
$1.78
DNN
+5.19%
$3.24
RGTI
+1.74%
$55.87
LAES
+19.88%
$7.34
ITP
+24.30%
$0.32
BYND
-22.70%
$0.80
EDHL
+95.69%
$0.97
INTC
-2.12%
$36.42
AXDX
-61.36%
$0.03
F
+1.81%
$11.75
CRML
+28.39%
$29.88
RXRX
+2.35%
$5.66
JOBY
+8.19%
$18.14
DVLT
+14.70%
$1.95
NAK
+2.81%
$2.73
IONZ
+6.95%
$2.46
DFLI
+44.03%
$1.57
ACHR
+2.46%
$13.08
GPUS
-6.62%
$0.40
AMD
+3.30%
$223.58
TSLA
-0.54%
$433.54
WULF
+12.21%
$15.71
ETHD
+5.41%
$3.51
TLRY
-2.96%
$1.63
ONDS
+17.24%
$10.81
MARA
+11.24%
$22.51
MP
+21.34%
$95.06
ERIC
+19.76%
$9.78
QBTS
+7.17%
$43.53
SOUN
+9.19%
$20.90
NUAI
+28.95%
$3.03
UUUU
+11.50%
$26.50
BTBT
+7.50%
$4.30
RR
+0.79%
$6.50
UAMY
+36.85%
$16.71
AAL
+3.79%
$12.18
KDLY
-1.56%
$0.85
BBD
+2.34%
$3.16
CLF
+2.20%
$14.13
SOFI
+3.38%
$28.05
NOK
-1.31%
$5.25
JDZG
+44.14%
$2.71
CIFR
+3.93%
$21.14
AREC
+30.92%
$6.51
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
AMZN
+1.71%
$220.07
ADAP
-10.05%
$0.16
CLSK
+11.02%
$22.25
IREN
+9.35%
$70.14
APLD
+4.26%
$35.70
RIG
-1.87%
$3.14
USAR
+2.43%
$39.62
SRM
+53.27%
$10.30
PLTR
+2.50%
$181.65
BTG
+1.22%
$5.37
NIO
-3.06%
$6.95
ABAT
+18.65%
$10.94
QUBT
+3.86%
$22.29
ASST
-5.09%
$1.02
WWR
+14.25%
$2.92
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
RF
+2.42%
$25.15
BMNR
-4.52%
$54.28
WLGS
-5.57%
$0.04
SNAP
-0.64%
$7.99
QS
-2.14%
$16.62
GGB
+2.85%
$3.24
ETWO
0.00%
$3.30
JBLU
+9.45%
$4.98
GWH
-19.99%
$7.24
RGTZ
-3.00%
$9.02
EOSE
+2.55%
$17.48
PFE
-0.14%
$24.69
BCRX
-11.29%
$6.24
ATXS
+38.84%
$11.76
AFMD
-34.94%
$0.18
NAKA
-6.15%
$0.80
BAC
+3.18%
$50.41
ABEV
+1.40%
$2.17
AQMS
+140.56%
$23.84
GWAV
+88.96%
$16.08
GDXD
+0.44%
$0.73
NB
+4.41%
$11.81
GRAB
+0.59%
$5.96
VALE
0.00%
$11.01
REKR
+22.35%
$2.54
OPI
-16.97%
$0.20
WFC
+7.55%
$84.88
URG
+5.67%
$2.14

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.